Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nuwacell Biotechnologies Co. Ltd. has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are both located within 1 distinct art unit, suggesting a unified technical focus for the company's current biotechnology filings. The workload is divided between 2 distinct examiners, providing two separate channels for review within the same technical classification.
The busiest examiner, JOHNSON, KARA D, is responsible for 1 pending office action. Since there are 2 distinct examiners for 2 pending office actions, the portfolio is not concentrated under any single individual's discretion. This structure allows the company to navigate the specific requirements of the 1 distinct art unit through multiple examiner perspectives. Practitioners can use the 2 pending office actions to gauge the consistency of the biotechnology art unit's application of patent law. The involvement of 2 distinct examiners for only 2 pending actions ensures that each application receives independent consideration. This distribution within 1 distinct art unit helps the company understand the technical boundaries for its current biotechnology innovations.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +39.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025588 | METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED HEMATOPOIETIC LINEAGE CELLS | NOBLE, MARCIA STEPHENS | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18025588 | METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED HEMATOPOIETIC LINEAGE CELLS | NOBLE, MARCIA STEPHENS | 1632 | §103DP | Non-Final OA | — | Pending | Mar 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial